The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
about
Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's DiseaseProgresses towards safe and efficient gene therapy vectorsCurrent progress in gene delivery technology based on chemical methods and nano-carriersMicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGFEfficient in vitro gene delivery by hybrid biopolymer/virus nanobiovectorsViral and nonviral delivery systems for gene deliveryBiological Risks and Laboratory-Acquired Infections: A Reality That Cannot be Ignored in Health BiotechnologyGene transfer and genome-wide insertional mutagenesis by retroviral transduction in fish stem cells.Intracellular trafficking of retroviral vectors: obstacles and advances.Gene therapy in gynecological cancer.In vivo delivery of miRNAs for cancer therapy: challenges and strategies.Long-Term Safety Follow-Up of Subjects Previously Treated with Non-Replicating Retroviral Vector-Based Gene Therapies.Manufacturing genetically modified T cells for clinical trials.Transporter molecules influence the gene expression in HeLa cells.Modified mRNA as a new therapeutic option for pediatric respiratory diseases and hemoglobinopathies.Toward Microsurgical Correction of Cleft Lip Ex Utero through Restoration of Craniofacial Developmental Programs.Therapeutic genome engineering via CRISPR-Cas systems.Engineered retroviral virus-like particles for receptor targeting.In vitro transfection mediated by dendrigraft poly(L-lysines): the effect of structure and molecule size.High Efficiency Ex Vivo Gene Transfer to Primary Murine B Cells Using Plasmid or Viral VectorsAdenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?Genetically engineered mesenchymal stem cells: The ongoing research for bone tissue engineering.Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes.Lentivirus-siNgR199 promotes axonal regeneration and functional recovery in rats.Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice.Exosome Biogenesis and Biological Function in Response to Viral Infections
P2860
Q26746174-8CA34AE0-D07C-4F30-BACD-8C54B947DC7DQ26781432-043B990E-2C81-4957-A281-3F0AC21CDAE4Q28659480-D044E8F0-A9E2-47A3-827F-74BDD5BFED28Q33906023-FA4D9C0F-BCA8-4ACB-96A5-2363BE9D225BQ34216718-53A1CDAB-8C7B-412E-BA4B-8DB45547780DQ34315475-D3293B73-93EE-4B06-BF5D-CC20F1855C91Q35545777-60193F3C-3B1E-49AE-80C0-B7277E961B82Q35647626-3C9D9325-9173-4781-87B4-01C1695996ABQ36314656-CE8A07BB-6F03-45A9-A8EB-ADCA512BD2F8Q36532089-25268CA2-29B5-4FD0-8977-67658720715DQ37228217-63D6D0A3-DF6E-4B70-B8FA-7BABB21D1A2BQ37410746-7F87798A-A265-48D8-80BF-F70C61F3151EQ38336760-A9C4024A-89CA-408B-B756-906D2BB449C5Q38510992-AA7FE8CA-8FD2-46E7-ADDA-42E04F7EF303Q38641141-BDD34D0C-8E46-4576-BB3C-BDAA3FD49A4AQ38740451-B397535B-E231-492E-ABC3-2672D9709B11Q38757432-EFC24E1D-4B0B-4C4A-A3C8-F0567ACA7573Q39077630-F350AF1B-D9D3-4378-BE48-C38092878EEAQ39227454-9CBBB472-444F-4FAC-81CB-D1CB67A4664EQ39553529-BCC7850B-95A9-4F0F-B56E-86FF66BD2159Q41699782-C0C319BF-4044-4921-BD1A-0B9ED39C89B4Q45325213-F8CEBFE0-E9B6-41B3-9D87-CF44CFA58E51Q48828725-0149709C-EEA4-4A4C-B1CF-7419D22547D9Q52743732-C11C146F-20EF-42CC-9F9B-D32EB2F1A75CQ53210902-B3C92396-D11D-4376-8A64-D844D9F53276Q53263258-37BD103C-6684-4B05-B455-D3F9F386AB4BQ58796191-EB3196B0-495F-4120-A783-AAE1FFE42559
P2860
The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
The use of retroviral vectors ...... vector-mediated gene delivery
@ast
The use of retroviral vectors ...... vector-mediated gene delivery
@en
The use of retroviral vectors ...... vector-mediated gene delivery
@nl
type
label
The use of retroviral vectors ...... vector-mediated gene delivery
@ast
The use of retroviral vectors ...... vector-mediated gene delivery
@en
The use of retroviral vectors ...... vector-mediated gene delivery
@nl
prefLabel
The use of retroviral vectors ...... vector-mediated gene delivery
@ast
The use of retroviral vectors ...... vector-mediated gene delivery
@en
The use of retroviral vectors ...... vector-mediated gene delivery
@nl
P2860
P3181
P356
P1476
The use of retroviral vectors ...... vector-mediated gene delivery
@en
P2093
Donald S Anson
P2860
P2888
P3181
P356
10.1186/1479-0556-2-9
P577
2004-08-13T00:00:00Z
P5875
P6179
1031108200